Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intramedullary megakaryocytes internalize released platelet factor 4 and store it in alpha granules.

Journal of thrombosis and haemostasis : JTH·2015
Same author

The immunomodulatory role of angiocidin, a novel angiogenesis inhibitor.

Current pharmaceutical design·2009
Same author

Endothelial apoptotic activity of angiocidin is dependent on its polyubiquitin binding activity.

British journal of cancer·2005
Same author

Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells.

The Journal of surgical research·2004
Same author

Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.

Pathology oncology research : POR·2002
Same author

Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment.

Blood·2001

Related Experiment Video

Updated: Jul 11, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Thrombospondin-induced adhesion of human platelets.

G P Tuszynski1, M A Kowalska

  • 1Department of Medicine, Medical College of Pennsylvania, Philadelphia 19129.

The Journal of Clinical Investigation
|April 1, 1991
PubMed
Summary

Platelet adhesion to thrombospondin (TSP) involves specific receptors. Integrin alphaIIbbeta3 and VLA-2 are key mediators of this interaction, crucial for understanding platelet function.

Area of Science:

  • Hematology
  • Cell Biology
  • Biochemistry

Background:

  • Platelet adhesion is a critical process in hemostasis and thrombosis.
  • Thrombospondin (TSP) is a major adhesive protein found in platelets and extracellular matrix.
  • Understanding the molecular mechanisms of platelet-TSP interaction is essential for developing antithrombotic therapies.

Purpose of the Study:

  • To investigate the specific platelet receptors involved in adhesion to thrombospondin (TSP).
  • To elucidate the roles of integrin alphaIIbbeta3 (GPIIb-IIIa) and VLA-2 in TSP-mediated platelet adhesion.

Main Methods:

  • Washed human platelets were allowed to adhere to TSP-coated microtiter plates.
  • Inhibition studies were performed using specific antibodies against platelet receptors and peptides.

More Related Videos

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
08:50

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets

Published on: April 9, 2018

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

Related Experiment Videos

Last Updated: Jul 11, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets
08:50

Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets

Published on: April 9, 2018

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

  • Platelet adhesion was quantified under various conditions, including the use of divalent cations and specific inhibitors.

    • Main Results:

    • Platelet adhesion to TSP was promoted by divalent cations (Mn2+, Mg2+, Ca2+).
    • Adhesion was inhibited by antibodies targeting TSP, RGD-containing peptides, anti-GPIIb-IIIa, and anti-VLA-2 antibodies.
    • Glanzmann's thrombasthenic platelets, lacking GPIIb-IIIa, showed reduced TSP adhesion, similar to normal platelets treated with anti-GPIIb-IIIa.
    • Anti-VLA-2 antibodies significantly inhibited TSP and collagen-induced platelet adhesion.

    Conclusions:

    • Platelet adhesion to TSP is a specific process mediated by distinct molecular pathways.
    • Both integrin alphaIIbbeta3 (GPIIb-IIIa) and VLA-2 play significant roles in TSP-dependent platelet adhesion.
    • VLA-2 is also involved in collagen-induced platelet adhesion, highlighting its broader role in platelet activation.